My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Azenta, Inc. - Common Stock (NQ:AZTA)

32.03 +1.90 (+6.31%)

Streaming Delayed Price Updated: 2:55 PM EDT, Aug 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Azenta, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Azenta Q3 Earnings Call Highlights ↗

Today 10:04 EDT

Azenta (NASDAQ:AZTA) reported third-quarter fiscal 2026 revenue that exceeded its outlook, as growth in recurring-revenue businesses and improved Multiomics performance helped offset continued...

Via MarketBeat

Topics Earnings

Azenta (NASDAQ:AZTA) Reports Upbeat Q2 CY2026

August 04, 2026

Life sciences company Azenta (NASDAQ:AZTA) announced better-than-expected revenue in Q2 CY2026, with sales up 12% year on year to $161.2 million. Its non-GAA...

Via StockStory

Azenta (AZTA) Reports Q2: Everything You Need To Know Ahead Of Earnings

August 02, 2026

Life sciences company Azenta (NASDAQ:AZTA) will be reporting results this Tuesday after the bell. Here’s what investors should know. Azenta missed analysts’ ...

Via StockStory

Topics Artificial Intelligence

3 Cash-Burning Stocks Walking a Fine Line

July 31, 2026

Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them...

Via StockStory

Topics Artificial Intelligence Economy

1 Unprofitable Stock Worth Your Attention and 2 We Avoid

July 23, 2026

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. Unprofi...

Via StockStory

Topics Climate Change

3 Unpopular Stocks We Steer Clear Of

July 22, 2026

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea...

Via StockStory

3 Reasons to Avoid AZTA and 1 Stock to Buy Instead

June 19, 2026

What a brutal six months it’s been for Azenta. The stock has dropped 30.3% and now trades at $24, rattling many shareholders. This was partly due to its soft...

Via StockStory

3 Cash-Heavy Stocks We Keep Off Our Radar

June 16, 2026

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they strugg...

Via StockStory

3 Hyped Up Stocks We Find Risky

June 11, 2026

Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such a...

Via StockStory

Topics Economy

3 Small-Cap Stocks with Open Questions

June 10, 2026

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...

Via StockStory

3 High-Flying Stocks Walking a Fine Line

June 08, 2026

“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the ...

Via StockStory

Winners And Losers Of Q1: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks

May 19, 2026

Looking back on drug development inputs & services stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Azenta (NASDAQ:AZTA) a...

Via StockStory

Azenta’s Q1 Earnings Call: Our Top 5 Analyst Questions

May 13, 2026

Azenta’s first quarter was marked by operational challenges and a more cautious demand environment, which contributed to results well below market expectatio...

Via StockStory

Topics Earnings

1 Russell 2000 Stock Worth Your Attention and 2 We Question

May 13, 2026

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ...

Via StockStory

Azenta (AZTA) Q2 2026 Earnings Call Transcript ↗

May 06, 2026

Azenta (AZTA) Q2 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Azenta (AZTA) Reports Earnings Tomorrow: What To Expect

May 04, 2026

Life sciences company Azenta (NASDAQ:AZTA) will be announcing earnings results this Wednesday before market hours. Here’s what you need to know. Azenta beat ...

Via StockStory

2 Cash-Heavy Stocks on Our Buy List and 1 We Turn Down

April 23, 2026

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face c...

Via StockStory

1 Healthcare Stock to Target This Week and 2 We Ignore

April 22, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-...

Via StockStory

3 Stocks Under $50 We’re Skeptical Of

April 17, 2026

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline...

Via StockStory

Curious about the stocks that are showing activity after the closing bell on Thursday? ↗

April 16, 2026

Via Chartmill

Wondering what's happening in today's after-hours session? ↗

April 01, 2026

Via Chartmill

Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know

March 27, 2026

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...

Via StockStory

Topics Economy Government Stocks

Q4 Earnings Highs And Lows: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks

March 22, 2026

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services ind...

Via StockStory

1 Cash-Producing Stock with Exciting Potential and 2 We Ignore

March 20, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Via StockStory

3 Unprofitable Stocks That Concern Us

March 19, 2026

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...

Via StockStory

Tenet Healthcare, Revvity, Avantor, Azenta, and Elanco Shares Plummet, What You Need To Know

March 06, 2026

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...

Via StockStory

Topics Economy Government World Trade

3 Reasons AZTA is Risky and 1 Stock to Buy Instead

March 02, 2026

Over the last six months, Azenta’s shares have sunk to $25.86, producing a disappointing 12% loss - a stark contrast to the S&P 500’s 6.6% gain. This was par...

Via StockStory

Topics Stocks

1 Small-Cap Stock to Research Further and 2 Facing Headwinds

February 26, 2026

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Via StockStory

3 Stocks Under $50 with Warning Signs

February 25, 2026

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to...

Via StockStory

Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know

February 23, 2026

A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court...

Via StockStory

Topics Government World Trade

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.